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We are interested in the factors involved in the anchorage of acetylcholinesterase (AChE) to the synaptic 
basal amina. Here, we report studies howing that heparin, a sulfated glycosaminoglycan, specifically 
solubilized AChE from endplate regions of rat diaphragm uscle. Of the several molecular forms of 
AChE present in that region, heparin only released the asymmetric Al2 and As forms of the enzyme. Our 
results trongly support he involvement of heparin-like macromolecules in the in vivo immobilization of
the collagen-tailed forms of AChE to the basal amina of the neuromuscular junction. 
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1. INTRODUCTION 
The acetylcholinesterase (AChE, EC 3.1.1.7) of 
vertebrate skeletal muscle can be separated by 
sedimentation analysis into several molecular 
forms [l]. The different AChE molecules may be 
classified as globular forms (monomers G1, dimers 
G2, tetramers G4) and asymmetric forms (contain- 
ing one, two or three tetramers, plus a collagen- 
like tail: A, As and Al2 [2]). In normal adult rat 
muscle, the A12 form which represents the major 
asymmetric form, is concentrated at the endplate 
region [2-41 where it is thought to be anchored to 
the basal lamina [2,5,6], a thin amorphous sheet of 
collagen, glycoproteins, and proteoglycans [7,8], 
which has been implicated in both pre- and post- 
synaptic differentiation [9, lo]. Interactions bet- 
ween the collagen-like tail of Al2 AChE and com- 
ponents of the basal lamina might account for the 
immobilization of the enzyme in this extracellular 
structure [1,2,6]. Indeed, isolated A12 AChE has 
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been shown to interact with both fibronectin [ll] 
and glycosaminoglycans (GAGS) [12]. However, 
there is no evidence that such interactions actually 
take place in situ. 
Here, we report that the GAG heparin solu- 
bilizes As and A12 AChE from the rat neuromus- 
cular junction. This result suggests that GAGS are 
implicated in the in vivo immobilization of asym- 
metric AChE at the synaptic basal lamina. 
2. MATERIALS AND METHODS 
The following chemicals were used: 
acetylthiocholine iodine, iso-OMPA, chondroitin 
sulfate and heparin from bovine lung (Sigma 
Chemicals); Protamine sulfate (Upjohn); 
5,5 ’ -dithio(bis)-dinitrobenzoic acid (Aldrich); 
Triton X-100 (New England Nuclear). The sucrose 
used was special Enzyme grade. The specific AChE 
inhibitor, BW284c51 dibromide was obtained 
from Burroughs Wellcome Co. The standard en- 
zyme ,&-galactosidase was obtained from Worth- 
ington Biochemicals. 
All experiments were made on male Sprague- 
Dawley rats (200-250 g body wt). 
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2.1. Rat diaphragm-muscle dissection 
Rat diaphragm muscles together with attached 
ribs were removed, washed in ice-cold saline, 
rapidly cleaned of most of the connective tissue 
and separated from the ribs. We divided 
diaphragms into regions containing endplates (the 
middle third of the muscle) and those without end- 
plates, by transversely cutting 2-3 mm strips of 
muscle, under a dissecting microscope [3,6,13]. 
2.2. Extraction of AChE activity 
Endplate and non-endplate regions of rat 
diaphragm muscle were dissected as above, and 
homogenized in ice-cold 50 mM Tris-HCl, 
(pH 8.4) plus 0.5% Triton X-100 or the same Tris- 
Triton buffer plus heparin, and centrifuged at 
20 000 x g for 20 min. In some experiments 
10 mM EDTA, 20 U aprotinin/ml, 2Oyg 
pepstatin/ml, 1 mM benzamidine, 1 mM N- 
ethylmaleimide and 0.1 mg bacitracin/ml were 
added to the Tris buffer. 
2.3. Linear sucrose density gradients 5-20% 
A Hoeffer gradient former was used. In general, 
a 200 ~1 sample was layered on the top of the gra- 
dient. Centrifugation was performed in a SW 50.1 
rotor at 4”C, at 46 000 rev./min for 8 h in a LS-65 
Beckman ultracentrifuge [ 14,151. Fractions were 
collected from the bottom and assayed for AChE 
activity. Sedimentation coefficients for AChE 
forms were estimated by comparison with that for 
&galactosidase (16.1 S). ,&Galactosidase was 
measured as in [ 161. 
2.4. AChE assay 
AChE activity was measured as in [ 171. All 
determinations were done at 37°C in a 1 ml reac- 
tion mixture, containing 100 mM sodium phos- 
phate buffer (pH 6.0), 0.75 mM acetylthiocholine 
iodide, 0.3 mM 5,5 ‘-dithio(bis)-dinitrobenzoic 
acid and 0.1 mM iso-OMPA. BW284c5 1 
dibromide (10 PM) was used as AChE specific 
inhibitor. 
3. RESULTS 
We first compared the total AChE activity 
released by heparin in both endplate and non-end- 
plate regions of adult rat diaphragm muscle. 
Heparin was able to increase the solubilization of 
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AChE activity only from the innervated regions 
(table 1). As little as 0.05 mg heparin/ml appeared 
to facilitate extraction of AChE acitvity. The max- 
imum percentage of solubilization obtained at 
l-3 mg heparin/ml is similar to that obtained with 
high ionic strength solutions (1 M NaCl). When 
the same experiment was repeated in neonatal rats 
(postnatal day 13), heparin was able to solubilize 
AChE activity from both endplate and non- 
endplate regions (for the latter the values were: 
Tris-Triton medium 0.4 + 0.01 pmol ACh. 
min-‘.g-‘; heparin containing medium 0.6 f 0.01; 
n = 4, P<O.Ol). Because in normal adult rat mus- 
cle, the Aiz form is concentrated in the endplate 
region [2-41, whereas in neonatal rats this form is 
distributed over the entire muscle fibre [ 18,191, the 
above results suggest a specific solubilization of 
the asymmetric or collagen-tailed forms of AChE 
by heparin. 
To determine the pattern of molecular forms 
solubilized by heparin from the endplate regions of 
adult rat diaphragm muscle, the supernatants were 
analyzed by sedimentation analysis [2,3,6]. Fig. 1 
Table 1 
Solubilization of AChE activity from endplate regions 
of rat diaphragm muscle by heparin (acetylcholin- 
esterase activity, pmol.min-‘.g muscle-‘) 
Treatment 
(a) Buffer 
Tris 
Triton X-100 
(b) Buffer 
Tris 
Triton X-100 
Heparin 
Endplate Non-endplate 
region region 
0.14 * 0.04 0.38 + 0.01 
1.17 -t 0.03” 0.39 f 0.01 
a P<O.O05 as compared to control without heparin in 
the endplate region. Each value is the mean f SEM of 
4 different experiments run in triplicate 
Endplate and non-endplate regions of rat diaphragm 
skeletal muscle were homogenized in either 50 mM 
Tris-HCl (pH 8.4), 0.5% Triton X-100, or the same 
extraction buffer plus 2 mg heparin/ml (from bovine 
lung, Sigma Chemicals). Homogenates were centrifuged 
at 20 000 x g for 20 min. Aliquots of the supernatants 
were added to assay mixture containing 0.75 mM acetyl- 
thiocholine iodide and 0.1 mM iso-OMPA [ 171. Assays 
were conducted at 37°C for 30-45 min 
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Fig. 1. Sedimentation profiles of AChE in endplate 
regions of rat diaphragm muscle after solubilization with 
and without heparin: (O---O) extraction in Tris-Triton 
buffer; (w) extraction in Tris-Triton-heparin 
buffer; 200/11 supernatant obtained as in table 1 were 
layered over linear S-20% sucrose gradients containing 
50 mM Tris-HCl (pH 8.4), 0.5% Triton X-100 and 1 M 
NaCI. Gradients were fractionated in -36 fractions and 
aliquots assayed as in table 1. (4) Sedimentation 
position of @-gafaetosidase (16.1 S) assayed in [16& 
shows sucrose gradient profiles of AChE activity 
solubilized in both buffer-detergent and buf- 
fer-detergent-heparin. The additional activity 
solubilized by heparin corresponds mainly to the 
Ai2 and As AChE forms (fig. 1). Table 2 shows the 
relative proportions of the various moleeuIar 
forms solubilized by this GAG. With minor dif- 
ferences, this profile is similar to that obtained 
when including f M NaCl in the Tris-Triton ex- 
traction medium without heparin, The addition of 
protease inhibitors to the extraction medium did 
not modify the profile obtained with heparin. 
Preliminary experiments on the specificity of the 
effect of heparin indicated that: 
(i) The presence of protamine in the extraction 
medium eleminates the capacity of heparin to 
extract AChE activity; 
(ii) Other GAG like chondroitin sulfate at a 
IO-fold higher concentration than heparin, is 
not abte to solubilize the esterase, 
Our results clearly demonstrate that the GAG 
heparin solubilizes AChE activity from endplate 
Table 2 
Molecular forms of AChE in control and heparin 
extracts of endplate regions of rat diaphragm muscle 
Proportions of molecular forms 
(a) Buffer 
GI-GI G4 As A12 
Tris 
Triton X-100 (Sls-283) (16!7lS) - - 
(b) Buffer 
Tris 
Triton X-100 62 12 6 19 
Heparin (57-66) (19-14) (S-7) (X7-21) 
The proportions of molecular forms were estimated 
from sedimentation profiles obtained from different 
animals. The values correspond to the mean of 3 animals 
and the numbers in parentheses to the range of the data. 
Endplate regions of the left hemidiaphragms were 
homogenized as in table 1. For the 3 expt, 200111 
supernatant were run in each gradient. The total AChE 
activity for the Tris-Triton supernatant was 
0.24 k 0.02 /r-m01 substrate hydroly~d.min-~.rnl-~ and 
for the heparin-~ont~n~ng supernatant, the activity was 
0.30 f 0.02, mean t SEM of 3 expt. Although the Gr 
and GZ forms represent .most of the activity in all 
gradients, they were not well resolved; therefore, only a 
global percentage is indicated. We could not detect the 
& form in our analyses, because of the presence of large 
amounts of globular forms at the corresponding region 
of the gradient 
regions of the rat diaphragm muscle and that most 
of this activity corresponds to the A8 and At2 
forms. There is strong evidence that the Aiz AChE 
form is associated to the basal lamina, both in 
muscle cells in culture [6] and at the adult 
neuromus~iar junction [Z]. The ~o~~agen~like tait 
of this form appears to be involved in the attach- 
ment of the enzyme, since collagenase is able to 
release active enzyme from muscle cells [6,20,21]. 
The collagen-like portion has also been shown to 
play a role in the interaction of the isolated Ai2 
with fibronectin [ll] and GAGS [12], two macro- 
molecules present at the muscle basement mem- 
brane [7,8]. It has been suggested that the aggrega- 
tion of asymmetric AChE at low ionic strength, 
could be related to the immobil~ation of the 
collagen-tailed AChE mofecules to the basal 
lamina [If_ In the eIectric organ of ~~~~~~o~~o~~~, 
the aggregation depends on a factor related to a 
GAG of the chondroitin sulfate type [12]. In mam- 
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mals however, no substantial release of AChE has 
been obtained after treating mouse myotube 
cultures [6] and endplate regions of mouse 
diaphragm [22] with condroitinase ABC and 
hyaluronidase, respectively. 
Heparin, a naturally occurring GAG, has been 
shown to release lipoprotein lipase from capillary 
walls [23], to facilitate extraction of fibronectin 
from lung parenchyma nd placental villi 1241, and 
to displace heparan sulfate from the surface of 
cultured cells [25]. These effects of heparin are 
probably related to its strongly polyanionic 
character, its high content of cw-L-iduronic acid 
and other still unclear stereochemical factors [26]. 
The solubilization of Ai2 and As AChE by heparin 
reported here is the first evidence linking this en- 
zyme to GAGS in situ. Our results do not allow 
conclusions on the nature of such an interaction. 
Nonetheless, in view of the behavior of heparin in 
other systems, we suggest hat heparin might be 
competing with heparin-like GAGS for binding 
sites on the collagen-like tail of the enzyme or 
other intermediate molecules involved in its an- 
chorage. Because heparin is structurally related to 
heparan sulfate, and proteoglycans containing this 
GAG are integral components of basement mem- 
branes [27], including the synaptic basal lamina of 
rat diaphragm muscle [S], heparan sulfate proteo- 
glycans appear as good candidates to be involved 
in the attachment of the asymmetric AChE to the 
extracellular matrix. At any rate, our results 
strongly support the involvement of GAGS in the 
immobilization of AS and A12 AChE forms to the 
basal lamina of the mammalian neuromuscular 
junction. 
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